Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Investigate Biological Correlates of Clinical Response to Panobinostat in Haematological Malignancy

NCT01658241 is registered in ClinicalTrials.gov with Peter MacCallum Cancer Centre, Australia as lead sponsor.

NCT NCT01658241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01658241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Investigate Biological Correlates of Clinical Response to Panobinostat in Haematological Malignancy
Lead sponsor
Peter MacCallum Cancer Centre, Australia
Phase
Phase 2
Overall status
Completed
Start date
July 16, 2012
Completion date
March 18, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma in leukemic phase, lymphoma with cutaneous involvement, marrow involvement with lymphoma, multiple myeloma, nodal lymphoma